Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha Infliximab

Inflammatory bowel diseases are chronic inflammation of the intestinal mucosa characterized by relapsing–remitting cycle periods of variable duration. Infliximab (IFX) was the first monoclonal antibody used for the treatment of Crohn’s disease and ulcerative colitis (UC). High variability between tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Blais, Anne, Lan, Annaïg, Blachier, François, Benamouzig, Robert, Jouet, Pauline, Couvineau, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253642/
https://www.ncbi.nlm.nih.gov/pubmed/37298505
http://dx.doi.org/10.3390/ijms24119554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253642/
https://www.ncbi.nlm.nih.gov/pubmed/37298505
http://dx.doi.org/10.3390/ijms24119554

Ejemplares similares